Cargando…

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?

BACKGROUND: Co-administration of letrozole during the first 5 days of ovarian stimulation was suggested to improve IVF outcomes in poor responders. We aimed to determine whether poor/sub-optimal responders might benefit from Letrozole co-treatment throughout the entire stimulation course. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapira, Moran, Orvieto, Raoul, Lebovitz, Oshrit, Nahum, Ravit, Aizer, Adva, Segev-Zahav, Aliza, Haas, Jigal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282086/ https://www.ncbi.nlm.nih.gov/pubmed/32513279 http://dx.doi.org/10.1186/s13048-020-00666-z

Ejemplares similares

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
por: Orvieto, Raoul, et al.
Publicado: (2021)

Future fertility of patients with zero oocytes yield in their first IVF cycle attempt
por: Orvieto, Raoul, et al.
Publicado: (2021)

Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
por: Orvieto, Raoul, et al.
Publicado: (2022)

Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis?
por: Lifshitz, Dror, et al.
Publicado: (2022)

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
por: Haas, Jigal, et al.
Publicado: (2017)

The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
por: Aizer, Adva, et al.
Publicado: (2022)

The in-vitro effect of gonadotropins’ type and combination on Granulosa cells gene expressions
por: Yung, Yuval, et al.
Publicado: (2022)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle
por: Haas, Jigal, et al.
Publicado: (2018)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
por: Kirshenbaum, M., et al.
Publicado: (2021)

Can expelled cells/debris from a developing embryo be used for PGT?
por: Aizer, Adva, et al.
Publicado: (2021)

Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers
por: Friedman-Gohas, Moran, et al.
Publicado: (2021)

Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?
por: Orvieto, Raoul, et al.
Publicado: (2020)

Degenerated oocyte in the cohort adversely affects IVF outcome
por: Atzmon, Yuval, et al.
Publicado: (2020)

Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage
por: Haas, Jigal, et al.
Publicado: (2014)

The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles
por: Li, Xiaojia, et al.
Publicado: (2023)

Do human embryos have the ability of self-correction?
por: Orvieto, Raoul, et al.
Publicado: (2020)

More is not always better–lower estradiol to mature oocyte ratio improved IVF outcomes
por: Aslih, Nardin, et al.
Publicado: (2021)

Does bariatric surgery improve ovarian stimulation characteristics, oocyte yield, or embryo quality?
por: Tsur, Abraham, et al.
Publicado: (2014)

The myths surrounding mild stimulation in vitro fertilization (IVF)
por: Orvieto, Raoul, et al.
Publicado: (2017)

Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers
por: Elizur, Shai E., et al.
Publicado: (2014)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report
por: Haas, Jigal, et al.
Publicado: (2014)

Cleavage-stage human embryo arrest, is it embryo genetic composition or others?
por: Orvieto, Raoul, et al.
Publicado: (2022)

Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
por: Eftekhar, Maryam, et al.
Publicado: (2020)

Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept
por: Orvieto, Raoul, et al.
Publicado: (2014)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Effects of letrozole co-treatment on the cumulative live-birth rate among normal responders in gonadotropin-releasing hormone antagonist cycles
por: Zhang, Shuyi, et al.
Publicado: (2022)

HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept
por: Haas, Jigal, et al.
Publicado: (2014)

Influence of seasonal variation on in vitro fertilization success
por: Kirshenbaum, Michal, et al.
Publicado: (2018)

Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders”
por: Orvieto, Raoul
Publicado: (2015)

A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation
por: Orvieto, Raoul
Publicado: (2015)

Comparison of The Effectiveness of Clomiphene Citrate versus Letrozole in Mild IVF in Poor Prognosis Subfertile Women with Failed IVF Cycles
por: Oktem, Mesut, et al.
Publicado: (2015)

Comparing of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles
por: Akbari, Soheila, et al.
Publicado: (2012)

Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination
por: Yun, Bo Hyon, et al.
Publicado: (2015)

The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being
por: Mohr-Sasson, Aya, et al.
Publicado: (2023)

Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A randomized trial
por: Pourali, Leila, et al.
Publicado: (2017)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice
por: von Schondorf-Gleicher, Anja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3opa1594vd6if2hucvo92bk89